Solid-phase synthesis of N-formylhydroxylamines (reverse/retro- hydroxamates)

Organic Letters

Volumn 7, Issue 17, 2005, Pages 3761-3763

  Price, Steve ^a   Osbourn, Susan E ^a  

^a Argenta Discovery Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; HYDROXAMIC ACID; METALLOPROTEIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG ANTAGONISM; SYNTHESIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; ENZYME INHIBITORS; HYDROXAMIC ACIDS; METALLOPROTEINS; MOLECULAR STRUCTURE;

EID: 24044512952     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0513995     Document Type: Article

References (17)

1. (a) Leung, D.; Abbenante, G.; Fairlie, D. P. J. Med. Chem. 2000, 43, 305-341.
2. (b) Kim, D. H.; Mobashery, S. Curr. Med. Chem. 2001, 8, 959-965, and references therein.
3. Kim, D. H.; Jin, Y. Bioorg. Med. Chem. Lett. 1999, 9, 691-696.
4. (a) Kamei, N.; Tanaka, T.; Kawai, K.; Miyawaki, K.; Okuyama, A.; Murakami, Y.; Arakawa, Y.; Haino, M.; Harada, T.; Shimano, M. Bioorg. Med. Chem. Lett. 2004, 14, 2897-2900.
5. (b) Duan, J. J.-W.; Lu, Z.; Xue, C-B.; He, X.; Seng, J. L.; Roderick, J. J.; Wasserman, Z. R.; Liu, R.-Q.; Covington, M. B.; Magolda, R. L.; Newton, R. C.; Trzaskos, J. M.; Decicco, C. P. Bioorg. Med. Chem. Lett. 2003, 13, 2035-2040.
6. Wada, C. K.; Holms, J. H.; Curtin, M. L.; Dai, Y.; Florjancic, A. S.; Garland, R. B.; Guo, Y.; Heyman, H. R.; Stacey, J. R.; Steinman, D. H.; Albert, D. H.; Bouska, J. J.; Elmore, I. N.; Goodfellow, C. L.; Marcotte, P. A.; Tapang, P.; Morgan, D. W.; Michaelides, M. R.; Davidsen, S. K. J. Med. Chem. 2002, 45, 219-232.
7. Park, J. D.; Kim, D. H. Bioorg. Med. Chem. Lett. 2003, 13, 3161-3166.
8. Wu, T. Y. H.; Hassig, C.; Wu, Y.; Ding, S.; Schultz, P. G. Bioorg. Med. Chem. Lett. 2004, 14, 449-453.
9. (a) Molteni, V.; He, X.; Nabakka, J.; Yang, K.; Kreusch, A.; Gordon, P.; Bursulaya, B.; Warner, I.; Shin, T.; Biorac, T.; Ryder, N. S.; Goldberg, R.; Doughty, J.; He, Y. Bioorg. Med. Chem. Lett. 2004, 14, 1477-1481.
10. (b) Hu, X.; Nguyen, K. T.; Verlinde, C. L. M. J.; Hol, W. G. J.; Pei, D. J. Med. Chem. 2003, 46, 3771-3774.
11. (c) Smith, H. K.; Beckett, R. P.; Clements, J. M.; Doel, S.; East, S. P.; Launchbury, S. B.; Pratt, L. M.; Spavold, Z. M.; Thomas, W.; Todd, R. S.; Whittaker, M. Bioorg. Med. Chem. Lett. 2002, 12, 3595-3599.
12. Watanabe, L. A.; Jose, B.; Kato, T.; Nishino, N.; Yoshida, M. Tetrahedron Lett. 2004, 45, 491-494.
13. (a) Salvino, J. M.; Mervic, M.; Mason, H. J.; Kiesow, T.; Teager, D.; Airey, J.; Labaudiniere, R. J. Org. Chem. 1999, 64, 1823-1830.
14. (b) Floyd, C. D.; Lewis, C. N.; Patel, S. R.; Whittaker, M. Tetrahedron Lett. 1996, 37, 8045-8048.
15. 2O, before being dried at 40°C to provide N-formyl Wang-O-hydroxylamine resin 2.
16. Heinonen, P.; Lonnberg, H. Tetrahedron Lett. 1997, 38, 8569-8572.
17. 2 (2 mL). The combined organic filtrates were concentrated to provide the desired N-formylhydroxylamine 4b.